Home › Hepatitis B › Maryland
Hepatitis B clinical trials in Maryland
7 studies for Hepatitis B are looking for participants at sites in Maryland.
Cities in Maryland
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- Grifols Investigative site, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07024641Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT07654283Evaluation of Patients With Liver Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Sep 24, 2026 · NCT00001971VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 18, 2026 · NCT06092333TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2025 · NCT04843852Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2025 · NCT06154278Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
- Mercy Medical Center, Baltimore
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 19, 2024 · NCT04588077From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.